Demant A/S

WBAG:DEMA Stock Report

Market Cap: €8.5b

Demant Valuation

Is DEMA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DEMA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
€65.94
Fair Value
41.2% undervalued intrinsic discount
17
Number of Analysts

Below Fair Value: DEMA (€38.8) is trading below our estimate of fair value (€65.94)

Significantly Below Fair Value: DEMA is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DEMA?

Key metric: As DEMA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for DEMA. This is calculated by dividing DEMA's market cap by their current earnings.
What is DEMA's PE Ratio?
PE Ratio24.9x
EarningsDKK 2.54b
Market CapDKK 63.13b

Price to Earnings Ratio vs Peers

How does DEMA's PE Ratio compare to its peers?

The above table shows the PE ratio for DEMA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average55.6x
TFX Teleflex
35.4x19.4%US$8.4b
MASI Masimo
117.4x41.5%US$9.2b
6869 Sysmex
33.9x12.9%JP¥1.8t
SN. Smith & Nephew
35.7x22.6%UK£8.9b
DEMA Demant
24.9x12.3%€63.1b

Price-To-Earnings vs Peers: DEMA is good value based on its Price-To-Earnings Ratio (24.9x) compared to the peer average (55.6x).

Price to Earnings Ratio vs Industry

How does DEMA's PE Ratio compare vs other companies in the European Medical Equipment Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
DEMA 24.9xIndustry Avg. 31.0xNo. of Companies9PE01632486480+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: DEMA is good value based on its Price-To-Earnings Ratio (24.9x) compared to the European Medical Equipment industry average (31x).

Price to Earnings Ratio vs Fair Ratio

What is DEMA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DEMA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate DEMA's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DEMA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€38.80
€40.22
+3.7%
11.3%€48.24€32.83n/a17
Jan ’26€35.38
€39.80
+12.5%
10.4%€46.93€32.85n/a17
Dec ’25€36.22
€39.73
+9.7%
10.5%€46.91€32.84n/a17
Nov ’25€34.92
€40.56
+16.1%
10.4%€48.28€33.53n/a17
Oct ’25€35.04
€40.41
+15.3%
11.1%€49.62€33.53n/a16
Sep ’25€38.34
€40.73
+6.2%
11.6%€49.60€30.83n/a16
Aug ’25€35.24
€42.20
+19.8%
13.9%€51.05€30.82n/a16
Jul ’25€40.48
€45.14
+11.5%
14.1%€53.63€35.93n/a16
Jun ’25€44.06
€45.21
+2.6%
14.3%€53.61€35.92n/a16
May ’25€44.96
€44.87
-0.2%
15.5%€53.62€32.17n/a16
Apr ’25€46.01
€45.55
-1.0%
15.8%€54.34€32.20n/a17
Mar ’25€47.37
€45.15
-4.7%
15.1%€53.66€32.20n/a17
Feb ’25€42.60
€40.07
-5.9%
13.5%€47.62€31.52n/a17
Jan ’25€39.68
€38.74
-2.4%
15.1%€46.96€24.82€35.3817
Dec ’24€37.89
€38.47
+1.5%
13.4%€44.94€24.82€36.2217
Nov ’24€36.36
€38.54
+6.0%
15.4%€45.55€24.79€34.9216
Oct ’24€39.27
€38.43
-2.1%
15.8%€45.62€24.82€35.0415
Sep ’24€38.26
€38.37
+0.3%
15.4%€45.62€24.82€38.3416
Aug ’24€36.30
€35.46
-2.3%
19.1%€44.28€24.15€35.2415
Jul ’24€38.78
€34.47
-11.1%
20.2%€44.32€24.18€40.4815
Jun ’24€36.20
€33.85
-6.5%
20.9%€44.30€24.17€44.0615
May ’24€38.92
€30.97
-20.4%
19.4%€44.28€24.15€44.9614
Apr ’24€32.23
€29.79
-7.6%
13.2%€36.91€24.16€46.0113
Mar ’24€28.06
€29.28
+4.3%
14.8%€36.94€24.18€47.3714
Feb ’24€26.69
€27.76
+4.0%
13.7%€34.15€22.86€42.6014
Jan ’24€25.98
€28.93
+11.4%
16.7%€38.31€22.18€39.6813
Analyst Price Target
Consensus Narrative from 17 Analysts
€40.16
Fair Value
3.4% undervalued intrinsic discount
17
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/19 03:20
End of Day Share Price 2025/01/17 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Demant A/S is covered by 49 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Morten LarsenABG Sundal Collier
Pierre-Yves GauthierAlphaValue
Gina FrancioliBank am Bellevue